Neuropeptide S vs Desmopressin
Head-to-head comparison of Neuropeptide S (Neuropeptide S) and Desmopressin (1-Deamino-8-D-arginine vasopressin) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | Neuropeptide S | Desmopressin |
|---|---|---|
| Category | Cognitive Enhancement | Cognitive Enhancement |
| Full Name | Neuropeptide S | 1-Deamino-8-D-arginine vasopressin |
| Molecular Weight | 2203 Da | 1069.22 Da |
| Half-Life | Minutes to <1 hour | 1.5-3 hours |
| Amino Acids | 20 | 9 |
| Typical Dose | Research-only; no validated human dose | 10-40 mcg intranasal |
| Route | Intracerebroventricular/Intranasal | Intranasal/Oral |
| Purity | ≥98% | ≥98% |
| Studies Count | 28 | 35 |
| Research Status | Pre-clinical | Clinical |
Neuropeptide S Benefits
- ✓anxiolysis
- ✓stress resilience
- ✓attention support
- ✓arousal modulation
Desmopressin Benefits
- ✓memory consolidation
- ✓reduced pressor burden
- ✓recall support
- ✓short-term learning
Neuropeptide S Dosing
0.1-1 nmol i.c.v. in animal studies|intranasal research-only exploration|no established human protocol
Desmopressin Dosing
intranasal research dosing|10-40 mcg or IU-equivalent studies|single-dose protocols
Neuropeptide S Side Effects
- ⚠sleep disruption
- ⚠headache
- ⚠jitteriness
Desmopressin Side Effects
- ⚠hyponatremia
- ⚠headache
- ⚠nasal irritation
Research Overview
Neuropeptide S
Animal studies suggest NPS can reduce anxiety-like behavior while altering wakefulness and alertness through the NPS receptor system. Human cognitive data are very limited, and it has no approved clinical indication.
Desmopressin
The literature is mixed, but desmopressin has shown memory-related effects in selected populations and experimental paradigms. Its cognitive effects are usually discussed as a vasopressin-pathway probe rather than a primary nootropic.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.